The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. (March 2014) |
The President's Cancer Panel is a three-person panel that reports to the president of the United States on the development and execution of the National Cancer Program. Members serve 3-year terms, and at least two of the three panel members must be distinguished scientists or physicians. The president appoints one of the members to a one-year chair position. The panel meets at least four times each year, and these meetings are open to the public.[1] The Panel was established in 1971 by the National Cancer Act.[2]
As of July 2022[update], the panel consists of Elizabeth M. Jaffee, M.D., FACR, FAACP, (chair), Mitchel S. Berger, M.D., FACS, FAANS, and Carol L. Brown, M.D., FACOG, FACS. [3]
References
edit- ^ "Division of Extramural Activities President's Cancer Panel Charter Summary" (PDF). National Institutes of Health. Retrieved 4 May 2019.
- ^ "Overview of National Cancer Act 1971". National Cancer Institute. Archived from the original on September 24, 2015. Retrieved 12 September 2015.
- ^ "President's Cancer Panel". Retrieved 7 August 2023.